Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT01689246 · COMPLETED
Trial details
- NCT number
- NCT01689246
- Sponsor
- TauRx Therapeutics Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-11-01
- Enrollment
- 891
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.